Category Archives: ZeroHedge

The Biotech (Short) Test

November 10, 2022 By in $SPSIBI, Biotech, David Weis, Dow 30, LABD, LABD-22-09, Positions, SPBIO, ZeroHedge 1 Comment

Proverbial ‘Gut-Check’

It looks bad for being short biotech and maybe it is.

However, as we’ll see below, the leveraged inverse fund LABD, could be completing its reversal set-up.

While today’s thrust higher in the overall markets was not unexpected (shown here and here), one should take note of the violence.

As of this post, from yesterday’s low to today’s high, the Dow has moved over 1,000-pts.

It’s what happens next that’s important.

Weak shorts are probably terrified, have covered, now wondering what went wrong.

So, let’s take a look at the short position on biotech SPBIO, and see if it really is ‘wrong’ (not advice, not a recommendation).

SPBIO, Leveraged Inverse Fund LABD, Daily

What we can see (above) is that LABD, is following the Wyckoff Schematic near exact for a spring set-up.

It’s just that today’s move is especially sharp and so one would think the set-up has failed … not so fast.

Another reason to think we’re completing a test of the spring, is below. Today is Fibonacci Day 34, from the high (low on SPBIO), set on September 26th.

We also have a potential trading channel as well.

As this post is being created, LABD is hovering at its lows; currently (as of 1:30 p.m., EST) trading at 19.89

Summary

Yesterday was an important day but it was not obvious, and not (yet) directly related to the markets.

A report was released on ZeroHedge (link here) which essentially confirms what some of us in the proletariat have known for years … if not decades.

It’s now out in the mainstream.

How long before the ‘elephant’ makes its way there also?

If indeed we’re at a reversal test of biotech and if that test passes (SPBIO downside continues), the move has the potential to be historic.

Positions, Market Stance (courtesy only, not advice).

LABD-22-09:

Price action blew through the stop located at 20.21 and is now hovering at those levels. The LABD position is being maintained but will likely be reduced in size as we head into the close (not advice, not a recommendation).

Special Note:

This sector and leveraged inverse LABD are highly volatile. Character of the market can change at any time.

LABD may be exited without notice.

Entry @ 19.88, 19.71, 21.23, 21.65, 22.16, 22.75 Stop @ 20.21

Note: Positions may be increased, decreased, entered, or exited at any time.

***, Indicates change

Stay Tuned

Charts by StockCharts

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279

Gold Leaves The Station … Again

November 9, 2022 By in $SPSIBI, Biotech, GLD, GOLD, LABD, LABD-22-09, Positions, SPBIO, Wyckoff, ZeroHedge

How Many Times?

How many times does gold need to ‘leave the station‘, before it’s actually left?

That’s probably a better question to ask rather than freaking out every time there’s a blip higher.

Was the recent ‘blip’ tradeable? Yes.

Is the move sustainable to the upside … probably not but only price action will tell.

Did Wyckoff analysis give advance notice that gold (GLD), could move higher?

Yes, it did … link here and here.

That first link even shows how far GLD, is likely to go, which at this point, is just ticks away.

Gold GLD, Daily

We’ll start first with the original forecast.

And the result (as of 1:20 p.m., EST).

We can see price action nearing the up-thrust (reversal) location.

Note: Penetration to the upside above resistance, does not necessarily mean it’s a short opportunity.

Any opportunity will be determined by price action itself.

Summary

Wyckoff analysis not only can provide potentials for price movement; when that move happens, it can also be a stabilizing factor so that one is not caught up in the usual media hysteria.

Meanwhile, back at the ranch, biotech sector (SPBIO) is still on track (ever so slowly) for a potential sustained move to the downside (not advice, not a recommendation).

Positions, Market Stance (courtesy only, not advice).

LABD-22-09:

Special Note:

This sector and leveraged inverse LABD are highly volatile. Character of the market can change at any time.

LABD may be exited without notice.

Entry @ 19.88, 19.71, 21.23, 21.65, 22.16, 22.75*** Stop @ 20.21

Note: Positions may be increased, decreased, entered, or exited at any time.

***, Indicates change

Stay Tuned

Charts by StockCharts

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279

‘No One In Control … ‘

November 8, 2022 By in LABD, LABD-22-09, Positions, TSLA, Wyckoff, ZeroHedge

Um, Yes There Is …

The latest from ZeroHedge is, ‘there’s no one in control.’

The latest from Wyckoff analysis is, ‘price action’s in control’, if you know where to look. 🙂

This week’s watch-list was laid out two days ago, here and so far, all topics discussed, are preforming as expected.

For this update (30-minutes before open) we’re going to focus on Tesla (TSLA).

Tesla, TSLA, Daily

There’s a lot going on.

We’re not in the ‘free-fall’ zone yet, but it’s getting close.

Downside volume has increased significantly.

The channel is being confirmed but we’re nearing support in the 188.00 – area (not shown).

Remember, when price action declines below known support levels, depending on the depth of penetration, we could be in Wyckoff spring position.

There could be an upside response to the break below current support located at approx. 198 – 200.

Summary

Q: Is TLSA, a short?

A: That’s at the trader’s discretion (not advice, not a recommendation).

My firm’s accounts do not have a position in TSLA … and if/when they do, it would likely be small.

It’s true the EV hysteria is a bubble. Supply chain collpase will make sure of that.

However, it does not even compare to the ‘elephant’, and we all know what that is.

Positions, Market Stance (courtesy only, not advice).

LABD-22-09:

Special Note:

This sector and leveraged inverse LABD are highly volatile. Character of the market can change at any time.

LABD may be exited without notice.

Entry @ 19.88, 19.71, 21.23, 21.65, 22.16*** Stop @ 20.21***

Note: Positions may be increased, decreased, entered, or exited at any time.

***, Indicates change

Stay Tuned

Charts by StockCharts

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279

The Market Set-Up … This Week

November 6, 2022 By in $SPSIBI, Biotech, Food Supply, GDX, Genesis 41, GLD, GOLD, Green Energy, ice-age-farmer, IWM, IYR, LABD, LABD-22-09, Positions, Prechter, QQQ, Real Estate, Russell 2000, S&P, S&P 500, SPBIO, SPY, The Speck, TSLA, XLF, ZeroHedge 2 Comments

What To Watch … Biotech, Gold, Real Estate, Tesla

Biotech:

There’re a lot of moving parts to biotech and it’s like a game of chicken.

Is there going to be another ‘planned’ event pulled out of the bag that requires ‘protection’ or will this side (and this one) win-out before that happens?

Price action’s always the final arbiter and right now, it’s positing lower.

Gold:

Gold (GLD) ‘blipped’ higher on Friday and the usual suspects are out touting the hyperinflation narrative.

Owning (some) precious metals seems to be a good thing.

However, the public constantly knee-jerks into this sector and is absolutely rabid in their behavior (i.e., silver stockpiles are running out!!!).

It suggests at least, there’s something else afoot.

Prechter published in the early 2000’s, Central Banks, are followers, not leaders. The fact they are buying gold at this point, may be a contrary indicator.

Talk about going against the herd. 🙂

Over and again, it’s the boring (does not generate ‘clicks’) food supply first, then gold and silver (not advice, not a recommendation).

Real Estate:

What can be said?

It’s the largest manufactured bubble in world history and it has already popped.

Thinking it’s all going to sort itself out in a year or two is delusional. We’ve probably got decades of bear market.

Tesla:

Anyone with an anode of research capability, knows the whole EV premise, is based on a falsehood.

However, that fact is probably not what’s going to bring Tesla (and the rest of the market) down.

Let’s stop for a moment and consider the above link which has been available for nearly four-years.

How many views? Just 9,824 (as of this post)

That equates to only 0.003% of the U.S. population.

As the global supply chains implode, getting parts and having stable infrastructure (i.e., electricity) will probably be the defining factor.

Now, on to the charts.

Biotech SPBIO, Daily Close

The following sessions will let us know if we’re at the right edge of the downtrend line.

We’ve already had an up-thrust reversal and a test of that reversal. last Friday was lower … probabilities point down.

Gold GLD, Daily

Looking at the chart on the strategic, longer term, Friday’s blip is hardly noticeable. We’ve already presented how this could be a minor up-thrust (reversal) in itself.

To keep the upside intact, price action must remain and continue above current levels.

Real Estate IYR, Daily

Real estate may be working its way into an up-thrust condition. As shown, Fibonacci Day 21 from the October 13th, low is this coming Thursday, the 10th.

According to the Economic Calendar there are several potential catalysts that may push the price above resistance (temporarily).

Tesla TSLA, Weekly

The short-term look has been presented here.

Longer term downside potential is disconcerting.

Major support near the 25-level.

Summary

When we look at last Friday’s action (table below), it’s clear SPBIO, was not part of the upside party.

Of course, we won’t know if it’s’ the downside leader until subsequent sessions.

In the meantime, the market positioning remains unchanged.

Positions, Market Stance (courtesy only, not advice).

LABD-22-09:

Special Note:

This sector and leveraged inverse LABD are highly volatile. Character of the market can change at any time.

LABD may be exited without notice.

Entry @ 19.88, 19.71, 21.23, 21.65 Stop @ 19.41

Note: Positions may be increased, decreased, entered, or exited at any time.

***, Indicates change

Stay Tuned

Charts by StockCharts

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279

Bond Reversal Bellwether

November 1, 2022 By in $SPSIBI, Biotech, Bonds, LABD, LABD-22-09, Positions, S&P, S&P 500, SPBIO, SPY, TLT, TMF, TMF-22-01, ZeroHedge

Is The ‘Collapse’ Back In Play?

When the market does not respond as expected, that means something else is happening.

Such may be the case for bonds.

Yesterday, we got this announcement during market hours.

Of course, the already hammered bond market (TLT), got hammed some more.

It’s what happened next, and what’s happening today, that’s important.

That is, the sell-off was quickly reversed (to the upside) with that upside continuing this session.

The bond supply is being absorbed.

So, what does that mean?

It’s possible, the bounce, melt-up, squeeze or whatever one wants to call it could be over. There may already be a ‘flight to safety’ if there’s such a thing these days.

But let’s not hypothesize on what could be happening. The market itself (price action), tells us.

Bonds TLT, Daily

At about mid-session, this is where we are.

We’re right at the downtrend line.

The attempt to mover lower (yesterday), has been rejected.

As a result of today’s new daily high, the stop on position TMF-22-01, has been moved up (not advice, not a recommendation).

So, we’re now between the downtrend and the ‘rejection’; something’s likely to break.

Summary

The S&P (SPY) just posted an up-thrust reversal early this session and is still moving lower as of this post.

Keep in mind, all of this is happening before any Fed announcement … as if the market has already decided.

A quick note on biotech, SPBIO.

Position size has been increased in SPBIO, leveraged inverse LABD, as shown below (not advice, not a recommendation).

This sector remains at The Danger Point®

If the bounce really is over, biotech is likely to get hit the hardest.

Positions, Market Stance (courtesy only, not advice).

TMF-22-01:

Entry @ 7.166, Stop @ 6.77***

***, Indicates change

LABD-22-09***

Entry @ 19.88, 19.71***, Stop @ 18.69***

Note: Positions may be increased, decreased, entered, or exited at any time.

Stay Tuned

Charts by StockCharts

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279

Bond Reversal Targets

October 29, 2022 By in Bonds, IYR, Positions, Real Estate, TLT, TMF, TMF-22-01, ZeroHedge 1 Comment

Trade or Strategic

It’s either a short-term trade or a strategic reversal.

On the strategic reversal side is this just out from ZeroHedge.

‘Inflation’ may have peaked; where have we heard that before.

However, the charts presented in that link, do show we’re at an extreme.

If we look at the TLT, price action itself, which is impulsive down, we’ll go with the short-term first (not advice, not a recommendation).

With that, Friday may have been the ‘test’ from our capitulation model.

The weekly chart of bonds TLT, shows the anticipated up-tick in MACD, as well as the measured move target from the terminating wedge.

Long Bond, TLT, Weekly

Note, the wedge has not (yet) broken to the upside … we’re still at The Danger Point®, where the trade could fail.

If we look at the daily chart, probabilities point higher.

Long Bond, TLT, Daily

If this past Friday was the ‘test’ of the move, the retrace was a very weak Fibonacci 23.6%.

A new daily high in the next session(s), will help to confirm we’re headed higher.

Positions, Market Stance (courtesy only, not advice).

TMF-22-01:

Entry @ 6.705, 7.166***, Stop @ 6.68

***, Indicates change

Note: Positions may be increased, decreased, entered, or exited at any time.

Summary

If bonds continue to move higher, with rates heading lower, what’s going to happen to real estate, IYR ?

The wheels of the real estate crash have already been set in motion. If bonds rise, rates fall and IYR moves higher, there are specific targets to watch for short opportunities.

We’ll discuss those targets and more, in the next ‘The Market Set-Up … This Week’

Stay Tuned

Charts by StockCharts

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279

The Market Set-Up … This Week

October 23, 2022 By in Bonds, Catherine Austin Fitts, DRV, DRV-22-05, GLD, Gold & Silver, IYR, Positions, Real Estate, Scott Walters, SLV, The Speck, TLT, TMF, Wyckoff, ZeroHedge 2 Comments

What To Watch … Gold, Bonds, & Real Estate

First off, ‘Goldman‘ says melt-up.

Not to be outdone, we have this ‘me too’ melt-up article as well.

Let’s not forget, all the ‘Fed must do something’ rumors and feigned concern by its members.

If anyone really wants to know the big picture, the overall plan (a wide majority do not), this interview may be the best explanation to-date.

With all of that, we certainly could get some kind of rally in the coming week. We’ll let the price action speak for itself.

As a reminder, Wyckoff analysis does not concern itself with press releases, rumors or ‘fundamentals’; Wyckoff himself, determined based on price action alone, they have no material effect on market movement.

In his words, ‘other forces are at work’, and it’s those forces that interest us.

Gold & Silver

As said in this update, gold (GLD) was just ‘ticks’ away from posting a new monthly low. In fact, it got just 0.24-pts, from a new low before rebounding.

Of course, each time we get any kind of rally in the metals, there’s the usual hysteria. Even though for the past seven months and counting, those rallies occur at lower and lower levels … i.e., a bear market.

Shown below, it’s in a trading channel with price action at the right-side channel line.

Gold (GLD) Weekly

The chart below gets closer-in.

From left-most contact point on the channel to the initial contact on the right side is a Fibonacci 13-weeks.

Also note, the weekly high posted at the center line is a Fibonacci 5-weeks from the left-most contact.

Highly emotional markets tend to adhere to Fibonacci until either the emotion wears off or ‘everybody’ recognizes the structure.

Obviously, to keep the channel intact, a lower open (and lower action) at the next session is needed.

Silver (SLV) has already been discussed in this update and this one.

Bond (TLT) Capitulation ?

Was this past Friday the day?

Gap-down trading on huge volume.

Looking at the daily chart of TLT below, Friday’s level of (down) volume has occurred only three times in the past three years.

Each time, there was a near immediate rebound or in the case of March 2021, the rebound came several weeks later.

Bonds (TLT) Daily

Moving in closer, we see the possibility of an ‘island-gap’ at the next open.

What could drive capital into the bond market?

Well, how about a ‘shock’ or continued market melt-down (not advice, not a recommendation).

A quick check of the local newsfeed (as of 12:45 p.m., EST) shows nothing on the horizon other than usual nuclear attack threats, power outages, child mutilation protests, marauding bears and the disarmament of Canadians.

Nothing to see here …

Real Estate

There is no mistake, events in real estate are happening at the fastest pace in recorded history.

As Scott Walters put it, over 10-million people bought into the ‘work from home’ hype and got themselves instantly (nearly) upside down in their transaction.

Now, the layoffs start.

Real Estate IYR, 3-Day Close

Zoom-in, on the channel

As the last update said, we’ll know soon enough if there is more upside or if last Friday was it, and the downdraft continues.

Stay Tuned

Charts by StockCharts

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279

The Market Set-Up … This Week

October 16, 2022 By in $SPSIBI, Basic Materials, Bonds, David Weis, DJUSBM, Gold & Silver, IYM, IYR, J.P. Morgan, LABD, LABD-22-08, Michael Cowan, Positions, SLV, SPBIO, Spring-to-Up-Thrust, Survival Lilly, TLT, TMF, TSLA, Van Metre, Wyckoff, ZeroHedge 4 Comments

What To Watch

First off, it’s nice to know, traders at J.P. Morgan, don’t have clue as what to do.

They say it themselves; Not One Person

On top of that, I’m supposed to pay money reading about how clueless they are. 🙂

No thanks. Let’s see if we can do better than the average ‘investment firm’.

Before we get started, a reminder; as Michael Cowen says:

‘It’s the bear market that reveals those who really understand’, not the bull market ‘geniuses‘.

With that, let’s get into it; first up, is silver.

Silver: Wyckoff Analysis Results

The downside reversal was identified to the day.

Adding to that post, Europeans could not only be freezing or starving this winter, but also subject to radiation poisoning.

Surely, they’re all thinking that ‘stack’ of silver is going to save them.

Silver (along with gold) remain trending lower.

Silver (SLV) is currently at support levels; therefore, some upward action (staying below SLV: 18.5) is normal behavior.

Bonds: Are They Ready?

Hold your nose … bonds could be setting up for a rally.

As Steven Van Metre reports here, the Fed ‘shenanigan’ meter is pegged.

Bonds, TLT Weekly

Note, the bullish TLT, set-up is not confirmed until MACD ticks higher (not advice, not a recommendation).

Also note the repeating pattern of ‘spring to up-thrust‘.

Last up, biotech

Biotech SPBIO, Hourly (Inverted)

We’re going to use the chart from yesterday’s post to set the stage for getting closer-in.

This past Friday’s early morning ‘spike’ is barely visible; the 30-minute (inverted) chart below, has more detail.

SPBIO, 30-minute (Inverted)

Price action rejected the lower levels (higher on SPBIO) and pulled away throughout the session. That ‘pulling away’ continued on, all the way into the close.

That’s a clue there may be follow-through at the next session.

If the early session opens ‘gap-higher’ (SPBIO, lower), into the resistance area (four magenta arrows, hourly chart), it would be the fourth time pressuring at this area; markets rarely hold a fourth attempt.

Summary

Of course, other markets are being watched like real estate (IYR), Tesla (TSLA), and even Basic Materials (DJUSBM), a potential sleeper for significant downside.

Updates are planned if/when low risk shows up.

Positions: Current Stance (courtesy only, not advice).

The following is the positioning of my firm’s main (largest) account.

LABD-22-08:

LABD Entry @ 25.1278, 24.735, 26.025, 22.99, 22.29***, Stop is @ LABD 21.23***

***, Indicates change

Note: Positions may be increased, decreased, entered, or exited at any time.

Stay Tuned

Charts by StockCharts

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279

The Usual Suspects

October 15, 2022 By in $SPSIBI, Biotech, Dr. Elder, Gwen Olsen, LABD, LABD-22-08, Livermore, Positions, SPBIO, The Epoch Times, The Speck, Usual Suspects, ZeroHedge 1 Comment

Special Biotech Edition

Bogart

An immense flood of data; research reports, lawsuits, expose articles and anecdotal evidence; every day, multiple times a day, something new.

Has the biotech technical (finally) lined up with the fundamental?

Those fundamentals are farther down but first, we’ll discuss the technical.

As a reminder, sometimes charts are inverted during analysis. This ‘trick’ was discovered years ago and is based on techniques used by Dr. Alexander Elder.

Biotech SPBIO, Weekly Close (Inverted)

We’ve taken the weekly closing chart of SPBIO ($SPSIBI, on StockCharts) and inverted it to mimic the action of inverse fund LABD.

The index has no volume; so LABD is used instead.

The magenta arrow shows the pivot point for the index, corresponds will all-time record volume on leveraged inverse LABD.

Next, we’ll get closer-in and look at the ‘pivot’ on the hourly chart (inverted).

SPBIO, Hourly (Inverted).

The magenta arrows show successive positions (Livermore ‘probes’) entered (via LABD) before the main entry @ LABD 22.99, which was 90% of position size up to that point.

The next day (Friday) had a gap-lower open that was quickly reversed. Position size was increased by another 5%, at LABD 22.29 (not advice, not a recommendation).

Effective position equates to LABD 23.17

Price action pulled away steadily from the early morning levels, suggesting a sustainable reversal.

The Fundamentals

Some of this stuff, you just can’t make up.

Listed in somewhat chronological order, here they are (not an exhaustive list).

No. 1

Pfizer hires 600 to help document adverse events. Wasn’t it supposed to be ‘safe and effective’?

No. 2

Pilot Shortage

Fired/quit because they refuse to get ‘protection’.

A possible corollary to what’s happened, via injection, we have this.

No. 3

Pfizer, nobody wants their product … after the rollout.

No. 4

Who could it be?

Previously unknown (or rare) problems and illness now starting to accelerate.

No. 5

We’re here to help.

No. 6

You mean, it was all a lie?

No. 7

The real reason for getting ‘tested’?

No. 8

What did the media know and when did they know it?

No. 9

It’s still a ‘suggestion‘ but the payouts to family members are real.

No. 10

It’s over … and then it’s not.

No. 11

We’ll keep it quiet, so no feelings get hurt.

No. 12

How bad is your batch? Let’s see.

No. 13

You mean, it was never tested? I’m shocked.

No. 14

After all that, maybe we can give it another shot.

No. 15

A potential infinite number of complications … nothing to see here.

No. 16

Getting away with it? Not so fast.

No. 17

Just had a heart attack? We can help.

No. 18

Limited Hangout? You decide.

No. 19

Lastly, this is what it’s really all about.

Recorded years ago. Did her ‘prophecy’ come true?

Stay Tuned

Charts by StockCharts

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279

Wheels Come Off … Biotech

October 13, 2022 By in $SPSIBI, Biotech, DRV, DRV-22-04, GDX, GDXJ, IYR, LABD, LABD-22-08, Positions, S&P, S&P 500, SPBIO, SPY, The Epoch Times, ZeroHedge

Unraveling, Quickly

This just out on ZeroHedge:

An Epoch Times article, using excerpts from a Lancet Report, linked here.

It’s best to let the reader sort out what it all means, arriving at one’s own conclusions.

Of course, the obvious problem, the ‘elephant’ is not addressed directly.

However, VAERS is quoted in The Epoch Times article, thus giving it legitimacy.

Leading The Downside

For some time, this site’s highlighted, biotech (SPBIO), as unique to all other indices save GDX, and GDXJ.

That is, it’s down the most since the bear market started.

As of today’s close, it’s down over – 54%, from all-time highs while the S&P is down only – 23.7%.

As documented over several years, the sector’s unique; it’s at risk (more than other indices) to implosion.

With today’s close, it looks like we’re at a critical juncture.

Biotech SPBIO, Weekly

The unmarked weekly chart

Compressed, with added trendlines.

It’s an obvious trading channel of immense size … but so is nearly everything else concerning these markets. We’re operating at unprecedented scale in unprecedented times.

But wait, there’s more.

The trading channel has Fibonacci time correlation(s).

We’ll expand the weekly chart for more clarity.

From channel entry, week ending 9/3/21, to the right-most contact point (week ending 9/16/22), is Fibonacci 55-Weeks.

Channel width measured from week ending 1/28/22, to the same contact-point, week ending 9/16/22, is a Fibonacci 34-Weeks.

We’re at The Danger Point®

Positions & Current Stance (courtesy only, not advice).

The following is the positioning of my firm’s main (largest) account.

DRV-22-04:

Entry @ 66.463, Stop @ 63.98

Discretionary exit (today) @ 75.96***

Trade Closed

LABD-22-08:

Entry @ 25.1278, 24.735, 26.025***, 22.99***, Stop is Open (to be set at next session)

***, Indicates change

Note: Positions may be increased, decreased, entered, or exited at any time.

Stay Tuned

Charts by StockCharts

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279